US2004191233A1PendingUtilityA1
Bifidobacteria and siderophores produced thereby and methods of use
Est. expiryJun 19, 2020(expired)· nominal 20-yr term from priority
Inventors:Daniel O'Sullivan
C12R 2001/01C12N 1/205A23C 19/062C07K 14/195Y02A50/30A61K 35/747Y10S435/822A23L 5/28A23V 2400/51
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides isolated Bifidobacterium strains that secrete a siderophore, and methods of using such strains. The present invention also provides a siderophore from bifidobacteria, and methods of obtaining and methods of using such siderophores.
Claims
exact text as granted — not AI-modified1 - 40 . Canceled
41 . A composition comprising an isolated Bifidobacterium and either a food or a beverage, wherein the isolated Bifidobacteriuin, when cultured in a medium comprising at least about 0.3 mM 2,2′-dipyridyl, secretes a siderophore, and wherein the siderophore inhibits growth of Lactococcus lactis.
42 . The composition of claim 41 wherein the food comprises a dairy product.
43 . The composition of claim 42 wherein the dairy product is a solid dairy product or a semi-solid dairy product.
44 . The composition of claim 42 wherein the dairy product is cottage cheese, cheese, powdered milk, milk, or yogurt.
45 . The composition of claim 41 wherein the beverage comprises milk, vegetable juice, fruit juice, soy milk, soybean milk, fermented soybean milk, or a fruit flavored beverage.
46 . The composition of claim 41 wherein the isolated Bifidobacterium is encapsulated or in a tablet.
47 . The composition of claim 41 wherein the composition comprises substantially no free iron, comprises an iron chelator, or a combination thereof.
48 . A method for administering a live microbial feed supplement, comprising:
providing an isolated Bifidobacterium, wherein the isolated Bifidobacterium, when cultured in a medium comprising at least about 0.3 mM 2,2′-dipyridyl, secretes a siderophore, and wherein the siderophore inhibits growth of Lactococcus lactis; and administering the isolated Bifidobacterium to an animal.
49 . The method of claim 48 wherein the animal is a human.
50 . The method of claim 49 wherein the human is an infant.
51 . The method of claim 48 wherein the isolated Bifidobacterium is present in a composition comprising either a food or a beverage.
52 . The method of claim 51 wherein the food comprises a dairy product.
53 . The method of claim 52 wherein the dairy product is a solid dairy product or a semi-solid dairy product.
54 . The method of claim 52 wherein the dairy product is cottage cheese, cheese, powdered milk, milk, or yogurt.
55 . The method of claim 51 wherein the beverage comprises milk, vegetable juice, fruit juice, soy milk, soybean milk, fermented soybean milk, or a fruit flavored beverage.
56 . The method of claim 51 wherein the isolated Bifidobacterium is encapsulated or in a tablet.
57 . The method of claim 48 wherein the isolated Bifidobacterium is secreting the siderophore when administered to the animal
58 . The composition of claim 51 wherein the composition comprises substantially no free iron, comprises an iron chelator, or a combination thereof.Join the waitlist — get patent alerts
Track US2004191233A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.